Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

Cabozantinib improves advanced kidney cancer survival: METEOR trial results

Prof Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
Cabozantinib improves advanced kidney cancer survival: METEOR trial results ( Prof Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )
27 Sep 2015

Melanoma immunotherapy latest and TVEC plus pembrolizumab

Dr Georgina Long - University of Sydney, Sydney, Australia
Melanoma immunotherapy latest and TVEC plus pembrolizumab ( Dr Georgina Long - University of Sydney, Sydney, Australia )
27 Sep 2015

Genetic screening of brain metastases could reveal new targets for treatment

Prof Priscilla Brastianos - Massachusetts General Hospital, Boston, USA
Genetic screening of brain metastases could reveal new targets for treatment ( Prof Priscilla Brastianos - Massachusetts General Hospital, Boston, USA )
27 Sep 2015

NETTER-1: Targeted radionuclide therapy improves PFS in mid-gut NETs

Prof Philippe Ruszniewski - Paris Diderot University, Paris, France
NETTER-1: Targeted radionuclide therapy improves PFS in mid-gut NETs ( Prof Philippe Ruszniewski - Paris Diderot University, Paris, France )
27 Sep 2015

RADIANT-4: Results of international trial show promise in the treatment of neuroendocrine tumours

Prof James Yao - University of Texas MD Anderson Cancer Center, Houston, USA
RADIANT-4: Results of international trial show promise in the treatment of neuroendocrine tumours ( Prof James Yao - University of Texas MD Anderson Cancer Center, Houston, USA )
27 Sep 2015

Mid-gut NETs respond to targeted radionuclide therapy: NETTER-1 results

Prof Philippe Ruszniewski - Paris Diderot University, Paris, France
Mid-gut NETs respond to targeted radionuclide therapy: NETTER-1 results ( Prof Philippe Ruszniewski - Paris Diderot University, Paris, France )
27 Sep 2015

Comment: EUROCARE-5, large blood cancer survival differences throughout Europe

Prof Martine Piccart - Jules Bordet Institute, Brussels, Belgium
Comment: EUROCARE-5, large blood cancer survival differences throughout Europe ( Prof Martine Piccart - Jules Bordet Institute, Brussels, Belgium )
27 Sep 2015

Comment: New immunotherapy options for kidney cancer

Prof Martine Piccart - Jules Bordet Institute, Brussels, Belgium
Comment: New immunotherapy options for kidney cancer ( Prof Martine Piccart - Jules Bordet Institute, Brussels, Belgium )
26 Sep 2015

Tackling global radiotherapy shortfall could save millions of lives and boost the economy of poorer countries

Prof Rifat Atun - Harvard University, Boston, USA
Tackling global radiotherapy shortfall could save millions of lives and boost the economy of poorer countries ( Prof Rifat Atun - Harvard University, Boston, USA )
26 Sep 2015

Large variations found in survival from blood cancers between European countries

Dr Milena Sant - Istituto Nazionale Tumori, Milan, Italy
Large variations found in survival from blood cancers between European countries ( Dr Milena Sant - Istituto Nazionale Tumori, Milan, Italy )
26 Sep 2015

CheckMate 025 trial results: Nivolumab versus everolimus in pre-treated advanced kidney cancer

Prof Padmanee Sharma - MD Anderson Cancer Center, Houston, USA
CheckMate 025 trial results: Nivolumab versus everolimus in pre-treated advanced kidney cancer ( Prof Padmanee Sharma - MD Anderson Cancer Center, Houston, USA )
26 Sep 2015

Everolimus for non-functional neuroendocrine tumours

Prof James Yao - University of Texas MD Anderson Cancer Center, Houston, USA
Everolimus for non-functional neuroendocrine tumours ( Prof James Yao - University of Texas MD Anderson Cancer Center, Houston, USA )
26 Sep 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation